Depreciation of Grace Therapeutics, Inc. from 31 Mar 2019 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Grace Therapeutics, Inc. quarterly and annual Depreciation in USD history and change rate from 31 Mar 2019 to 30 Jun 2025.
  • Grace Therapeutics, Inc. Depreciation for the quarter ending 30 Jun 2025 was $2,000, a 100% increase year-over-year.
  • Grace Therapeutics, Inc. annual Depreciation for 2024 was $7,000, a 36% decline from 2023.
  • Grace Therapeutics, Inc. annual Depreciation for 2023 was $11,000, a 91% decline from 2022.
  • Grace Therapeutics, Inc. annual Depreciation for 2022 was $124,000.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

Grace Therapeutics, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $2,000 +$1,000 +100% 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025 2026 Q1
Q2 2024 $1,000 -$6,000 -86% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025 2026 Q1
Q2 2023 $7,000 -$160,000 -96% 01 Apr 2023 30 Jun 2023 10-Q 09 Aug 2024 2024 Q1
Q2 2022 $167,000 $167,000 +$167,000 01 Apr 2022 30 Jun 2022 10-Q 11 Aug 2023 2023 Q1
Q1 2022 $0 $0 -$1,000 -100% 01 Jan 2022 31 Mar 2022 10-K 23 Jun 2023 2023 FY
Q4 2021 $1,000 $0 $0 01 Oct 2021 31 Dec 2021 10-Q 14 Feb 2022 2021 Q3
Q3 2021 $1,000 $0 -$56,000 -100% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2021 2021 Q2
Q2 2021 $57,000 $0 -$86,000 -100% 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022 2022 Q1
Q1 2021 $143,000 $1,000 -$409,000 -100% 01 Jan 2021 31 Mar 2021 10-K 21 Jun 2022 2022 FY
Q4 2020 $552,000 $0 -$110,000 -100% 01 Oct 2020 31 Dec 2020 10-Q 14 Feb 2022 2021 Q3
Q3 2020 $662,000 $56,000 -$16,000 -22% 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021 2021 Q2
Q2 2020 $678,000 $86,000 -$3,000 -3.4% 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021 2021 Q1
Q1 2020 $681,000 $410,000 +$26,000 +6.8% 01 Jan 2020 31 Mar 2020 10-K 29 Jun 2020 2020 FY
Q4 2019 $655,000 $110,000 01 Oct 2019 31 Dec 2019 10-Q 09 Feb 2021 2021 Q3
Q3 2019 $72,000 01 Jul 2019 30 Sep 2019 10-Q 16 Nov 2020 2021 Q2
Q2 2019 $89,000 01 Apr 2019 30 Jun 2019 10-Q 13 Aug 2020 2021 Q1
Q1 2019 $384,000 01 Jan 2019 31 Mar 2019 10-K 29 Jun 2020 2020 FY

Grace Therapeutics, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $7,000 -$4,000 -36% 01 Apr 2024 31 Mar 2025 10-K 23 Jun 2025 2025 FY
2023 $11,000 -$113,000 -91% 01 Apr 2023 31 Mar 2024 10-K 23 Jun 2025 2025 FY
2022 $124,000 +$124,000 01 Apr 2022 31 Mar 2023 10-K 21 Jun 2024 2024 FY
2021 $0 -$143,000 -100% 01 Apr 2021 31 Mar 2022 10-K 23 Jun 2023 2023 FY
2020 $143,000 -$267,000 -65% 01 Apr 2020 31 Mar 2021 10-K 21 Jun 2022 2022 FY
2019 $410,000 +$26,000 +6.8% 01 Apr 2019 31 Mar 2020 10-K 22 Jun 2021 2021 FY
2018 $384,000 01 Apr 2018 31 Mar 2019 10-K 29 Jun 2020 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.